Clinical and pathological heterogeneity of four common fusion subtypes in Xp11.2 translocation renal cell carcinoma
BackgroundXp11.2 translocation renal cell carcinoma (Xp11.2 tRCC) is a group of rare and highly heterogeneous renal cell carcinoma (RCC). The translocation involving TFE3 and different fusion partners lead to overexpression of the chimeric protein. The purpose of this study is to explore the clinico...
Main Authors: | Wei Guo, Yiqi Zhu, Xiaohong Pu, Hongqian Guo, Weidong Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1116648/full |
Similar Items
-
Gender difference analysis of Xp11.2 translocation renal cell carcinomas’s attack rate: a meta-analysis and systematic review
by: Wenyuan Zhuang, et al.
Published: (2020-08-01) -
Are tumor-associated micro-angiogenesis and lymphangiogenesis considered as the novel prognostic factors for patients with Xp11.2 translocation renal cell carcinoma?
by: Wenliang Ma, et al.
Published: (2020-12-01) -
Molecular Heterogeneity of Xp11.2 Translocation Renal Cell Carcinoma: The Correlation Between Split Signal Pattern in FISH and Prognosis
by: Zhu Y, et al.
Published: (2021-03-01) -
Bilateral Xp11.2 translocation renal cell carcinoma: a case report
by: Takashi Karashima, et al.
Published: (2018-11-01) -
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas
by: Jiale Zhou, et al.
Published: (2022-07-01)